The summit invites international, leading healthcare technology companies and research centers to present and demo their latest achievements.
Digital healthcare allows to: Diagnose -> Manage - > Predict -> Prevent health issues.
They come from the US, Israel, Europe and Asia.
A great opportunity also for Swiss e-health technology providers to present and introduce themselves.
The entire focus will be on soon usably healthcare applications and systems.
It is not a scientific medical conference.
Also discussed are: the increasing recognition of the need for health data exchange, better cyber-security, regulations and data policies like for patient records.
The program showcases how digital technologies enable new and improved healthcare applications and services and will help to address mega challenges such as that of aging populations and rising healthcare costs.
Assaf Barnea, CEO, Sanara Ventures - a house for healthcare innovators
Sanara Ventures is one of the leading healthcare investment platforms in Israel backed by Philips & Teva, providing pre-seed, seed and A round financing.
Ralf Haller, President, CEO, High-Tech Connect Suisse &
R. Haller IT Marketing
How it works: AI system can quickly interpret eye scans from routine clinical practice with unprecedented accuracy. It can correctly recommend how patients should be referred for treatment for over 50 sight-threatening eye diseases as accurately as world-leading expert doctors.
Why it is important:
For whom it is: eye hospitals and eye doctors
"Dr. Google" or how Google Health is aiming to create the world’s healthcare information cloud: organizing the world’s healthcare information, making it accessible, secure, and useful by all to improve the health and healthcare of people and communities globally.
How it works: Our Imaging Analytics Engine uncovers brain, lung, liver, cardiovascular and bone disease in CT scans, 40 different conditions in X-rays scans , and breast cancer in 2D mammograms with an ever growing pipeline.
Why it is important: When your site’s entire imaging volume is processed by Zebra-Med and given our growing number of solutions we can guarantee a rate of up to $1/scan.
We promise to provide all our current and future AI driven algorithmic capabilities while maintaining this transparent, accessible All-in-One model.
For whom it is: radiologists, hospitals
How it works: We connect patients with their healthcare providers in the clinical and research world, 24/7, on all devices.
We empower clinical and research work by including patient reported outcome and real world data.
Why it is important: To strengthen the traditional patient-doctor relationship by integrating the platform with primary software used by doctors and with medical devices used by patients.
For whom it is: for doctors, patients and reseachers
Break
Introduction and moderation by Dr. Lambert Montevecchi, Founder & Managing Director, Boost Consulting
At Corti, we imagine a future where every medical professional can perform at an elevated level thanks to a new kind of human-computer partnership.
Corti provides this partnership by utilizing machine learning technology to enhance the decision-making abilities in real-time.
In this talk Lars will present Corti’s current machine learning stack with demo’s of the system.
Lars will also dive into Corti’s current research and applications in enhancing the ability to augment even further.
Lunch break and Healthcare Technology Exhibition
Philipp Löpfe, Economic Journalist, Watson.ch
Introduction and moderation by Prof. Dr. Christiane Brockes, Co-founder & CEO, alcare
How it works: Our patents enable pulse oximetry monitoring that includes SpO2 and pulse rate taken from the wrist anytime, anywhere.
Comfortable to wear, spot-check operational mode, color OLED display, long-life rechargeable battery, medical grade accuracy.
Why it is important: Straight forward and easy to operate wrist-sensor
medical device creates a great user experience
that boosts patient compliance.
For whom it is: for patients and physicians
How it works: Sleeprate helps you on your path to better sleep: from monitoring, to assessment, to CBTi coaching. Sleeprate works on any leading wearables including Apple Watch, Fitbit, Garmin and more, that fully integrated with our sleep tracking app.
Why it is important: If sleep deprivation is an issue for you, you’re not alone.
Over 50% of the global population suffer from sleep deprivation or poor sleep.
The Sleeprate app brings wellness to the nights, for better days ahead.
For whom it is: for patients and physicians
How it works: Tyto is a handheld exam kit and app that lets you perform guided medical exams with a healthcare provider, anytime, anywhere. With Tyto, you can receive a diagnosis, a treatment plan, and a prescription if needed, all from the comfort of home.
Why it is important: Tyto goes beyond a phone or video chat with a doctor by providing an on-demand, clinic-quality medical exam, right from your home, so you can know with certainty what to do next. Debates about whether to rush to the emergency room are over. With Tyto, you’ll know immediately if action needs to be taken or if you can go back to sleep.
For whom it is: for professionals and patients
Introduction and moderation by Dr. Daniel Vonder Mühll, Executive Director, Personalized Health and Related Technologies (PHRT) - ETH Zürich
Whole Genome Sequencing is already impacting the lives of thousands of patients across the world, especially those suffering from rare diseases. We will present case studies of specialists who were able to target efforts and treat the individuals, as well as patients who had their life changed after years of "undiagnosed Odyssey".
How it works: Accelerating the fight against cancer requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform.
Together, we can learn from the experience of every patient.
Why it is important:
For whom it is: community oncology, life science companies, academics, hospitals
How it works: PHREND bases on the data of disease progression of thousands of MS patients and offers physicians and patients both a personalised comparison between different MS therapies and gives them a second opinion on what drugs are likely to be most effective in their case.
Why it is important:
For whom it is: patients and doctors
How it works: FDNA is analyzing the world’s most comprehensive database of genetically relevant phenotypic information, crowdsourced from clinicians, labs and researchers.
Why it is important: To detect physiological patterns that reveal disease-causing genetic variations.
For whom it is: Clinicians, labs, researchers and bioinformatics organizations
Break & Healthcare Technology Exhibition
Prof. Dr. Eric Topol, Executive VP, Scripps Research, leading cardiologist who has embraced the study of genomics and the latest advances in technology to treat chronic disease and author of "Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again".
introduction and moderation by Prof. Dr. Alfred Angerer, Head of Healthcare Management, ZHAW
IT Security
Dr. Lukas Ruf, Consecom & Patrik Greuter, Kantonsspital Winterthur
End
Dr. Lambert Montevecchi
Prof. Dr. Eric Topol
Dr. Elisabeth Stühler
Assaf Barnea
Prof. Dr. Christiane Brockes
Prof. Dr. Alfred Angerer
Bill Evans
Eyal Toledano
Ofer Harpak
Paola Castelli
Andrea Riposati
Dr. Daniel Vonder Mühll
Frédéric Briguet
Carlos Rodes
Arnd Lülsdorf
Dr. Ulrich Mühlner
Dr. Nathalie Bloch
Dr. Michelle Livne
Philipp Löpfe
Dr. Charit Bhograj
Veronica Jagher
Dr. Lars Maaløe
Dekel Gelbman
Ralf HallerMy research is on indvidualized medicine, using the genome and digital technologies to understand each person at the biologic, physiologic granular level to determine appropriate therapies and prevention.
An example is the use of pharmacogenomics and our research on clopidogrel (Plavix).
By determining the reasons for why such a large proportion of people do not respond to this medication, we can use alternative treatment strategies to prevent blood clots.
Lambert has spent 24 years working for leading international management consulting firms focused on performance improvement, business transformation and cost reduction.
(Alexander Proudfoot, MCGplc, Hitachi Consulting, Renoir Group) In these companies, he held senior executive positions as business process analyst, head of auditing and assessment, business development VP and country manager.
The experience accumulated during those years conducting performance assessments and driving change management projects for more than 200 clients belonging to the world’s leading multinational corporations, government organizations, as well as to large and medium sized private companies in all types of industries and services in 36 countries, has provided Lambert with a truly global vision.
This business vision was further enhanced by spending 3 years working for the Exigen Group, a San Francisco based, multinational information technology corporation operating in the field of digital platforms for the telecommunication and financial services industry as well as offshore BPO (Business Process Outsourcing).
Lambert applied his business analysis skills to bridge information technology with operational needs and constraints and perfected his understanding of how to make them work best in the client’s interest. In 2007 Lambert decided to apply his change management expertise to the Healthcare sector by creating Boost Consulting.
Boost was founded with a mission to implement process, systems, organizational and behavioral changes in healthcare delivery, in order to improve the patient pathway; its quality and performance, whilst achieving measurable operational and financial gains.
Lambert and his team had observed that most management consultancy firms greatly underestimated the extreme complexity of healthcare and that none where offering integrated and tailor-made solutions to simultaneously address the four (processes, systems, organization, behavior) pillars of a change management program.
This insight spurred Boost to truly focus on the patient, not just in words but in action, and develop a unique approach to concurrently implement process, systems, organizational and behavioral improvements in healthcare institutions around the world.
Boost has carried out 25 projects for major hospitals in four continents and all are references. Lambert continues to act as an advisor and analyst for management consulting firms and is an “ambassador” for several hospitals.
Lambert is multicultural: French citizen, attending English, American, French schools and universities in Africa, Europe and the USA. Trilingual in English, French and Italian. Holds a PhD in political science and international relations. Lives near Milan, Italy
Co-founder and CEO of the company alcare
University Zurich: lectures „Clinical Telmedicine and e-Health“
The company alcare offers comprehensive services in the Active Assisted Living (AAL), e-health and telemedicine: the implementation of digital technologies and services in the private living sector, general support of the end-users and education of professional staff. The main goal is to provide confidence, acceptance and knowledge of the fast-growing eHealth-sector and to increase the self-determination, quality of life and safety.
Mr. Assaf Barnea is a seasoned entrepreneur and venture professional, with extensive, multidisciplinary experience in building innovation platforms and leading commercialization processes in healthcare.
He leads Sanara Ventures, a healthcare innovation fund backed by Phillips and Teva. In addition to leading Sanara, Mr. Barnea chairs the Life Science Advisory Board at The Israel Export Institute, on behalf of the Israeli government, promoting and advancing the export of Israeli technologies in the medical, biotech, pharma and digital fields in global markets. A valued consultant, Mr. Barnea also advises the World Bank’s IFC venture capital team and is a co-founder of the IFC’s Tech Emerge initiative; a unique acceleration platform that connects healthcare startups from around the world with leading corporationsand hospitals in emerging economies.
Formerly, Mr. Barnea was one of the founders of CardioSense, a medtech startup company that developed a probe for early shock detection in various medical settings.
Before lending his multidisciplinary acumen to Sanara Ventures, Assaf served as CEO of Kinrot Ventures, spearheading its acquisition by Hutchison Water in 2012. Prior to this, he headed business development at Mekorot, Israel’s national water company, where he oversaw the establishment of WaTech, the Entrepreneurship & Partnership Center for Water Technologies. For his accomplishments in both Mekorot and Kinrot, he received the Cleantech Group’s Innovation Hero Award in April 2013, which recognizes individuals whose commitment, drive and passion have made a tangible difference for innovation in general and specifically for many start-up companies.
Previously, Mr. Barnea served for four years as director of business development at Comverse, where he also co-chaired the Mobile Marketing Association.
A unique highlight in Assaf’s story is his former stint as a college basketball player at New Jersey’s Seton Hall University, where he won the Big East championship against Georgetown. He went on to play professional basketball in Israel’s national league, while completing multiple academic degrees.
A certified lawyer, Mr. Barnea holds both law and business degrees from the Interdisciplinary Center in Herzelia, as well as a BA in political science and psychology from Tel-Aviv University.
Dr. Elisabeth Stühler is specialized in developing and utilizing advanced data analytics methodology for predictive healthcare. Her focus is on biostatistics, machine learning, supervised and unsupervised learning algorithms, and she has published various articles on the application of those. She specializes in finding solutions for highly complex and diverse datasets. Before she joined the Data Analytics & Modelling team of PwC Digital Services, she was a PhD candidate at the Computer Science department of University of Konstanz, where she finished her thesis on feature detection and development in medical imaging data of the human brain. During that time she gained more than 4 years of experience in advanced feature extraction, data modeling and statistical validation.
Bill Evans is the Managing Director of Rock Health, the first venture fund dedicated to digital health. Prior to joining Rock Health, Bill held leadership roles within Roche Diagnostics delivering clinical decision support software and at Genentech developing partnerships expand the use of "real-world data" in the drug development process.
Innovator, techie, mobile and internet junkie.
Serial entrepreneur, Business/Technology leader with 3 meaningful exits:
Founded NetWiz, Merge with BATM (went to IPO in London) became later BATM/Telco systems (served as BATM/Telco CTO),
2 M&A: Founded WiNetworks - sold to Siemens and founded Spectrum (Own DBD GmbH) - sold to Deutsche Telekom
Ofer responsible for the development and launch of numerous products , and few breakthrough technology multidisciplinary projects and product .
Ofer served in one of the elite technology unit in the Israeli army and holds BSc from the Technion in Haifa Israel
Oxitone background:
Oxitone developed an end to end solution for Digital continuous care for patients at home.
We developed a wrist worn pulse oximeter ( without the bulky fingertip probe) that measure accurately 24/7 every second:
We can detect changes and trends and send automatic alarm messages when something go wrong.
Paola Castelli is Regional Sales Manager at SOPHiA GENETICS for Western Europe (France, Switzerland, Belgium, and Luxembourg).
She obtained a Master’s degree in Molecular Biology from the University of Milan.
Paola successively held positions of Product Manager for electrophoresis, chromatography, and sequencing.
She joined SOPHiA GENETICS in 2016 and has been a Territory Manager for Spain, Portugal, Africa and Middle-East for 2 years.
Andrea Riposati is the CEO & co-founder of Dante Labs, the global whole genome data company.
Prior to Dante Labs, Andrea was a Sr. Product Manager at Amazon in Seattle, where he launched 3D Printing and the Marketplace for Professional Medical Supplies.
Andrea holds an MS summac cum laude in Business from Bocconi University and an MBA from Harvard Business School.
Dr. Ulrich Mühlner is the CEO and co-founder of docdok.health as well as a graduate and PhD biochemist.
He spent many years working for the Boston Consulting Group in the healthcare sector before joining Novartis in 2009, where he was responsible for important initiatives as Director and Head of Corporate Strategy, especially in the field of digital health.
Arnd Lülsdorf is an IT Professional who held various Consulting, Solution Architecture, Solution Sales, Account Management as well as Sales Management roles in Switzerland over the last 19 years.
He started working with Global Life Science clients in Switzerland and EMEA in 2001. Initially focussing on Security requirements and Workflow Solutions he later supported customers on infrastructure strategies for public, private and hybrid Cloud, Real World Evidence and more recently machine learning applications for Healthcare and Life Sciences.
Recent projects addressing Chatbots, Knowledge Management, Marketing. Arnd hold a Diploma for electrical engineering from RWTH Aachen.
Dr. Daniel Vonder Mühll is managing Director of SystemsX.ch, the Swiss Initiative in Systems Biology aiming at establishing Switzerland in the forefront of this interdisciplinary research field in life sciences.
It is a consortium with nine universities and three research institutions as partners: ETH Zurich, EPF Lausanne, the Universities of Basel, Bern, Fribourg, Geneva, Lausanne, Neuchâtel, Zurich, the Swiss Institute of Bioinformatics, the Friedrich Miescher Institute and the Paul Scherrer Institute.
Following studies in Computer Science Frédéric Briguet gained extensive experience within international institutions and companies such as Hewlett-Packard, Nestle, Medtronic, Boston Scientific
In 2002, Frédéric joined Nestlé working on projects as Global eCommerce solutions for Nestlé ProfessionalTM, NespressoTM and DolceGustoTM. He managed the innovation lab for new technology and participated in the shift from traditional to new media.
He joined in 2010 NayaMed/Medtronic Europe to develop a full online, worldwide business for medical devices, as the Head of Marketing and eBusiness.
Certified from the IMD Frédéric also participated in the review of the best-selling book “Value Proposition that sells”.
In 2013, Frédéric worked as Business Model manager for Boston Scientific with the aim to manage the service digital health transformation of the company in Europe.
Frédéric joined MindMaze in 2018 fulfilling the role of Head of Marketing for clinical evidence and sales, responsible for defining the commercial strategy and business model for the healthcare branch of MindMaze: MindMotionTM
Dr. Bloch is the head of the ARC Innovation Center at Sheba.
Dr. Bloch returned to Israel after 14 years in Boston. There she served as an internal medicine specialist at Mount Auburn Hospital, a Harvard University affiliated hospital and as a Medical Director at MACIPA (Independent Physician Association). She was a senior Fellow for Innovation in Healthcare Delivery at Harvard Medical School and received her Master's Degree in Public Administration from the Harvard Kennedy School.
WeFitter was started by Carlos Rodes and Roger Del Sol. They're two quite ordinary individuals from Barcelona, Spain who've been best friends since college... and while they barely have anything in common, except both being from Barcelona, speaking the same language, loving the same restaurants, sharing the same humor and liking the same music, they coincidentally both love working out... however, unfortunately their occasional lack of motivation had somewhat of a negative impact on their year-round workout routine.
So, with the power of observation and vision, they arrived at the following conclusion: thousands of amateur sportspeople were generating a huge amount of data thanks to sports tracking apps and wearable devices. This information could be used by companies in multiple ways; it could show them the correlation between how many of their workers exercise actively, and how well their workers perform at work... or it could provide a sport-clothing company with the exact information they need to decide what the most popular sport is at a given time, so that the company can then target developing clothes for this specific market.
Finally, the two founders thought that exercising is something great - not just for an individual, but for everyone; people who exercise tend to walk more and use less transportation, they tend to spend more time outside, thus caring more about their environment and they tend to care more about their nutrition - meaning they're healthier.
Now these are indeed great side-effects of working out, and both Carlos and Roger thought it was time to reward this greatness. So, after managing to prove the concept, WeFitter was born.
Philipp Löpfe was named Swiss Economic Journalist of the Year in 2012 and 2015.
He works for the online news portal «Watson». He has a Masters degree in Arts (University of Zürich) and an MBA (Universitiy of St. Gallen).
In his long career Mr. Löpfe was editor-in-chief of «Tages-Anzeiger» and «SonntagsBlick».
He has written several books, the most recent one, together with Oliver Fiecheter, is called «Aufstieg der digitalen Stammesgesellschaft» (Ascent of the digital tribal society).
Philipp Löpfe is married and lives in Zürich.
Dr Charit is an Interventional Cardiologist by training who completed his MBBS in Bijapur, MD in General medicine in Belgaum and DM in Cardiology in Chennai and returned back home to Bangalore as a consultant cardiologist at Vikram Hospital and the head of clinical service at Baptist Hospital.
Realizing that there was a significant gap in the delivery of health care leading to millions of lives lost, he founded Tricog Health one of the world’s largest health AI companies that uses modern technology enabling rapid diagnosis and management of heart disease.
As the founding CEO of FDNA, Dekel Gelbman leads the corporate and business strategy of an innovative digital health company that develops technologies and SaaS platforms used by thousands of clinical, research and lab sites globally in the clinical genomics space. Prior to joining FDNA, Mr. Gelbman was a practicing corporate and transactional attorney working for leading law firms, working closely with a variety of technology and biotech companies at all stages.
As Director Industry Solutions for Healthcare in Western Europe, Veronica is responsible to drive strategy and business development for public and private healthcare organizations, working together with a community of professionals across the region, with a main focus on Spain, Portugal, Italy, Austria, Switzerland and Belgium.
Veronica spearheads key initiatives on digital transformation in health, mobilizing industry stakeholders on key topics like cloud-first innovation and artificial intelligence in health. She is an active contributor of the European Cloud in Health Advisory Council, a vendor-neutral C-level forum aimed at fostering cloud-first innovation in the health sector.
From 2015-2017, Veronica held the role of Business Development Leader for Healthcare in Italy, working with both healthcare customers and partners / ISVs.
Before joining Microsoft, Veronica worked 15 years for IBM, covering both consultancy, sales and business development roles. Veronica graduated in Physics from Padua University and holds an International MBA from Henley Management College.
Lars is the Chief Technology Officer and co-founder of Corti and has previously worked with companies like Apple and Issuu. He holds a PhD from the Technical University of Denmark with an extensive research and publication history within semi-supervised and unsupervised machine learning. He was nominated PhD of the year by the department of applied mathematics and computer science.
My more than two decades work experience has spanned various marketing, project management and business development roles, based on my training as an electrical engineer and masters in Telecommunication Systems (Karlsruhe Institute of Technology).
My career started while at university, when I took an assistant role in the USA. Later, I worked as an IT project manager for large key account clients at CompuNet in Munich and also worked in Hong Kong supporting the Asian region.
This prompted my move to Silicon Valley where I lived for many years, working as a Product Manager for successful startups building some of the first data communication equipments in the market. (first gigabit ethernet router/switch)
Since 2001, I provide product marketing and business development support and have organised different high-tech business events in Switzerland.
I am the organiser of about 15 per year national and international high-tech trends, innovation, entrepreneurship and technology business events in Switzerland, among them:
+ Silicon Valley meets Switzerland, svms-event.ch
+ Startup-Nation Israel meets Switzerland, startup-nation.ch
+ Chinese-Swiss High-tech Summit, china-innovation.ch
I am also the founder and president of the first - not for profit - "High-Tech Connect suisse" association encouraging and inspiring high-tech business development.
I started teaching the course "Global Innovation Ecosystems" and others at universities and look forward doing more of these as I love sharing and discussing with smart minds of all ages and cultures.
On invitation only or with a "High-tech Connect suisse" Membership.
Please use your Code to sign on.
